AI assistant
Sending…
Innoviva, Inc. — Director's Dealing 2014
Jan 17, 2014
32090_dirs_2014-01-16_9af16766-616e-43f3-872a-51d131ca549b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2014-01-06
Reporting Person: LEE JUNNING (Sr. VP, Technical Operations)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 141141 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $12.40 | 2014-09-02 | Common Stock (10980) | Direct | |
| Stock Option (Right to Buy) | $16.00 | 2014-10-03 | Common Stock (18750) | Direct | |
| Stock Option (Right to Buy) | $16.00 | 2014-10-03 | Common Stock (19250) | Direct | |
| Stock Option (Right to Buy) | $18.37 | 2015-02-09 | Common Stock (9900) | Direct | |
| Stock Option (Right to Buy) | $29.65 | 2016-02-07 | Common Stock (9900) | Direct | |
| Stock Option (Right to Buy) | $34.00 | 2017-02-13 | Common Stock (10400) | Direct |
Footnotes
F1: Immediately exercisable.
More from Innoviva, Inc.
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Major Shareholding Notification
2026
Feb 12
Director's Dealing
2025
Nov 24